AI-generated summary
The authors compared a Class IV laser photobiomodulation therapy with a 21-day meloxicam course in 20 dogs with bilateral hip osteoarthritis. They report better pain and function scores in the laser group at several time points up to 30 days, with improved joint range of motion from 15 to 90 days. The study was randomized and double-blinded, but the abstract reports a small sample.
- Participants
- 20
- Who or what was studied
- Dogs with bilateral hip osteoarthritis (moderate in 26 joints and severe in 14), mean age 8.3 years
- Limits stated in the abstract
- The abstract reports a small sample of 20 dogs and does not report a wavelength for the laser.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on avmajournals.avma.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Osteoarthritis, Photobiomodulation, Visual analogue scale, Control group, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.